Investor Relations

Investor Relations

Corporate Profile

Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders. We commercialize a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets.

Our prescription WatchPAT family of products, which utilizes the PAT signal, is designed to enable patients suspected to have sleep related breathing disorders to easily conduct sleep apnea tests in the comfort of their homes in accordance with a physician’s instructions, as authorized by qualified medical personnel while delivering the treating physicians with comprehensive, accurate and reliable results to aid in the diagnosis of sleep apnea.

 
Stock Information
Press Releases
Feb
2021
Itamar Medical to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Tuesday, March 2, 2021
Feb
2021
89% of Survey Participants Think They Know What Sleep Apnea Is, Yet Deeper Analysis Suggests that their Understanding is Superficial
Feb
2021
Itamar Medical to Participate in Upcoming Investor Conferences
Feb
2021
Itamar Medical Announces Closing of Public Offering of American Depositary Shares and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs
Feb
2021
Itamar Medical Announces Pricing of Public Offering of American Depositary Shares
Feb
2021
CORRECTION – Itamar Medical Announces Proposed Offering of American Depositary Shares
Investor Events
Mar
2021
41st Annual Cowen Health Care Conference
Mar
2021
Q4 2020 Itamar Medical Ltd. Earnings Conference Call
Feb
2021
10th Annual SVB Leerink Global Healthcare Conference
Nov
2020
Piper Virtual Healthcare Conference
Investor Presentations
Management